References
- Brenner W. E. The current status of prostaglandins as abortifacients. Am J Obstet Gynecol 1975; 123: 306
- Cohen E., Ballard C. A. Consumptive coag-gulpathy associated with intra-amniotic saline instillation and the effect of intravenous oxytocin. Obstet Gynecol 1974; 43: 300
- Comparison of intra-amniotic prostaglandin F2α and hypertonic saline for induction of second trimester abortion. Br Med J 1976; 1: 1373
- Corlett R. C., Ballard C. A. The induction of medtrimester abortion with intra-amniotic prostaglandin F2α. Am J Obstet Gynecol 1974; 118: 353, 1974
- Edelman D. A., Brenner W. E., Mehta A. C., Philips F. S., Bhatt R. V., Bhiwandiwala P. A comparative study of intra-amniotic saline and two prostaglandin F2α dose schedules for midtrimester abortion. Am J Obstet Gynecol 1976; 125: 188
- Goodlin R. C., McLennan C. E., Choyce J. M., Lee R. S., Stickler J. E. Therapeutic abortion with hypertonic intra-amniotic saline. Obstet Gynecol 1969; 34: 1
- Goodlin R., Newell J., O'Hare J., Steerz H. Cervical fistula—a complication of midtrimester abortion. Obstet Gynecol 1972; 40: 82
- Grimes D. A., Schultz K. F., Cates W., Jr, & Tyler C. W., Jr. Midtrimester abortion by intra-amniotic prostaglandin F2α Safer than saline?. Obstet Gynecol 1977; 49: 612
- Hasson H. M. Topical uterine anesthesia: a preliminary report. Int J Gynaecol Obstet, (in press).
- Motashaw N. Personal communication